Targeting TGF-β1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis

Abstract

This TGF-beta1 peptide-based vaccine, which suppressed excessive TGF-beta1 bioactivity, may prevent the development of intestinal fibrosis and associated complications, presenting a novel approach in the treatment of IBD.